Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
#TradFi交易分享挑战
#mrna
$MRNA 🧬 $MRNA Technical Outlook — Biotech Giant Approaching Critical Decision Zone
MRNA remains one of the most volatile biotech stocks in the market. While vaccine revenues slowed after the pandemic boom, investors are now focusing on Moderna’s long-term mRNA pipeline, cancer vaccine developments, and next-generation therapeutics.
📊 Current Price: 47.96
Current technical structure:
⚠ Price remains under long-term pressure
⚠ Volatility still extremely high
⚠ Biotech sector weakness continues
✅ Potential accumulation zones starting to appear near lows
━━━━━━━━━━━━━━━
🎯 Key Support Zones
🟢 47.00 — Immediate support
🟢 45.50 — Critical demand zone
🟢 42.00 — Major long-term support
Holding above 47 may allow a short-term stabilization attempt.
━━━━━━━━━━━━━━━
🚨 Resistance Levels
🔴 50.00 — Psychological resistance
🔴 53.50 — Strong breakout barrier
🔴 58.00 — Major recovery target
A breakout above 50 with strong volume could improve market sentiment rapidly.
━━━━━━━━━━━━━━━
📈 Bullish Recovery Scenario
If: ✔ Buyers defend 47 support
✔ Positive biotech news emerges
✔ mRNA pipeline optimism increases
Potential upside targets: 🎯 50.00
🎯 53.50
🎯 58.00
━━━━━━━━━━━━━━━
📉 Bearish Risk Scenario
If: ❌ 47 support breaks
❌ Biotech sector selling continues
❌ Weak earnings or pipeline concerns appear
Possible downside targets: ⚠ 45.50
⚠ 42.00
⚠ New yearly lows
━━━━━━━━━━━━━━━
🧠 Market Perspective
MRNA is no longer trading purely as a vaccine company.
The market is now pricing future potential in: • Cancer vaccines
• Personalized medicine
• AI-driven drug discovery
• Next-generation mRNA therapies
This creates both: 🔥 Massive upside potential
⚠ High speculative risk
━━━━━━━━━━━━━━━
💡 Trade Idea
Entry Zone: 47–48
TP1: 50
TP2: 53.50
TP3: 58
Stop Loss: Below 45.50
Biotech stocks remain highly volatile — strict risk management is essential.
━━━━━━━━━━━━━━━
🔥 High risk + high reward setup. If biotech sentiment recovers, MRNA could become one of the strongest rebound plays in TradFi markets.
#mrna
$MRNA 🧬 $MRNA Technical Outlook — Biotech Giant Approaching Critical Decision Zone
MRNA remains one of the most volatile biotech stocks in the market. While vaccine revenues slowed after the pandemic boom, investors are now focusing on Moderna’s long-term mRNA pipeline, cancer vaccine developments, and next-generation therapeutics.
📊 Current Price: 47.96
Current technical structure:
⚠ Price remains under long-term pressure
⚠ Volatility still extremely high
⚠ Biotech sector weakness continues
✅ Potential accumulation zones starting to appear near lows
━━━━━━━━━━━━━━━
🎯 Key Support Zones
🟢 47.00 — Immediate support
🟢 45.50 — Critical demand zone
🟢 42.00 — Major long-term support
Holding above 47 may allow a short-term stabilization attempt.
━━━━━━━━━━━━━━━
🚨 Resistance Levels
🔴 50.00 — Psychological resistance
🔴 53.50 — Strong breakout barrier
🔴 58.00 — Major recovery target
A breakout above 50 with strong volume could improve market sentiment rapidly.
━━━━━━━━━━━━━━━
📈 Bullish Recovery Scenario
If: ✔ Buyers defend 47 support
✔ Positive biotech news emerges
✔ mRNA pipeline optimism increases
Potential upside targets: 🎯 50.00
🎯 53.50
🎯 58.00
━━━━━━━━━━━━━━━
📉 Bearish Risk Scenario
If: ❌ 47 support breaks
❌ Biotech sector selling continues
❌ Weak earnings or pipeline concerns appear
Possible downside targets: ⚠ 45.50
⚠ 42.00
⚠ New yearly lows
━━━━━━━━━━━━━━━
🧠 Market Perspective
MRNA is no longer trading purely as a vaccine company.
The market is now pricing future potential in: • Cancer vaccines
• Personalized medicine
• AI-driven drug discovery
• Next-generation mRNA therapies
This creates both: 🔥 Massive upside potential
⚠ High speculative risk
━━━━━━━━━━━━━━━
💡 Trade Idea
Entry Zone: 47–48
TP1: 50
TP2: 53.50
TP3: 58
Stop Loss: Below 45.50
Biotech stocks remain highly volatile — strict risk management is essential.
━━━━━━━━━━━━━━━
🔥 High risk + high reward setup. If biotech sentiment recovers, MRNA could become one of the strongest rebound plays in TradFi markets.